The single most accurate serum marker of atherosclerotic cardiovascular risk — more predictive than LDL-C.
Apolipoprotein B (ApoB) is a structural protein embedded in every atherogenic lipoprotein particle — LDL, VLDL, IDL, and Lp(a). Because each of these particles carries exactly one ApoB molecule, measuring serum ApoB gives a direct count of atherogenic particles. This is a fundamentally different and more accurate measure of cardiovascular risk than LDL-cholesterol, which measures the cholesterol content of the particles (not the count).
The clinical consensus has moved decisively toward ApoB over the last decade. Cardiology societies in Europe and increasingly in the US recommend ApoB as the primary cholesterol target. The reason is simple: two people with identical LDL-C values can have very different particle counts, and the person with more particles has higher risk. ApoB resolves this ambiguity in a single test.
ApoB is influenced by: dietary saturated fat (primary lifestyle lever), alcohol intake, hepatic function, genetic variants (familial hypercholesterolemia, ApoE genotype), insulin resistance (raises ApoB), thyroid function (hypothyroidism raises ApoB), body composition, and pharmacologic agents — statins, PCSK9 inhibitors, bempedoic acid, ezetimibe, GLP-1 agonists (which lower ApoB). Exercise has only modest direct effects unless it drives meaningful body-composition change.
ApoB is one of the biomarkers that GLP-1 protocols reliably improve — most users see 10–25% reductions at maintenance doses. Any comprehensive longevity or peptide protocol should track ApoB at baseline and every 3–6 months. Changes in ApoB precede changes in downstream clinical events by years, which makes it uniquely valuable for protocol decisions: you can adjust based on ApoB without waiting for a cardiovascular event. Request "ApoB direct" or "Apolipoprotein B" specifically — it is not included in standard lipid panels.
Upload any lab PDF and MyProtocolStack maps your values to ApoB and 40+ other biomarkers. StackAI interprets the trend in context of your protocol.
Start tracking →Informational only — not medical advice. Reference ranges vary by lab and individual context. Work with a licensed provider to interpret your specific results.